1. Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non‐small cell lung cancer patients with neoadjuvant immunotherapy
   Qilin Huai et al, 2023, Cancer Science CrossRef
2. Prognostic role of C-reactive protein to albumin ratio in cancer patients treated with immune checkpoint inhibitors: a meta-analysis
   Menglu Dai et al, 2023, Frontiers in Oncology CrossRef
3. The impact of nutritional status in nivolumab-treated patients with advanced esophageal cancer
   Naoki Takegawa et al, 2023, PLOS ONE CrossRef
4. 進行食道癌に対する化学療法，化学放射線療法における栄養管理
   豊 木村, 2023, The Japanese Journal of SURGICAL METABOLISM and NUTRITION CrossRef
5. Prognostic Value of Lymphocyte-to-Monocyte Ratio (LMR) in Cancer Patients Undergoing Immune Checkpoint Inhibitors
   Luying Wan et al, 2022, Disease Markers CrossRef
6. Prognostic Value of Absolute Lymphocyte Count in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab Plus Ipilimumab
   Kosuke Ueda et al, 2023, Journal of Clinical Medicine CrossRef
7. Pretreatment total lymphocyte count as a prognostic factor of survival in patients with recurrent cervical cancer after definitive radiation-based therapy: a retrospective study
   Ekasak Thiangphak et al, 2023, Obstetrics & Gynecology Science CrossRef